NoviBio
Beijing
About NoviBio
NoviBio focuses on early tumor treatment and the development of novel immune cell therapy and first-in-class gene therapy pharmaceuticals with totally independent intellectual property rights.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2025)
- Website: newishes.com
Industries & Categories
Health Care, Health Diagnostics
Canonical: https://fsome.com/organization/novibio-38728 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.